EVERSANA™ is the leading independent global commercialization partner. With complete commercialization infrastructure in the US, EU, and UK, EVERSANA is uniquely positioned as a global commercial partner.

We are at BIO to discuss:

• Commercialization partnerships in the US, UK, and Europe

• Commercial partnerships for assets approaching LOE in the US

• Commercialization partnerships for novel therapeutics (first-time launchers)

• Direct-to-patient models